RESUMEN
OBJECTIVE: To analyse the relative percentage of acute recreational drug toxicity emergency department (ED) presentations involving the main drug groups according to age and sex and investigate different patterns based on sex and age strata. METHODS: We analysed all patients with acute recreational drug toxicity included by the Euro-DEN Plus dataset (22 EDs in 14 European countries) between October 2013 and December 2016 (39 months). Drugs were grouped as: opioids, cocaine, cannabis, amphetamines, gamma-hydroxybutyrate (GHB), hallucinogens, new psychoactive substances (NPS), benzodiazepines and ketamine. Descriptive data by age and sex are presented and compared among age/sex categories and among drug families. RESULTS: Of 17,371 patients were included during the 39-month period, 17,198 (99.0%) had taken at least one of the investigated drugs (median age: 31 years; 23.9% female; ethanol co-ingestion recorded in 41.5%, unknown in 31.2%; multiple drug use in 37.9%). Opioids (in 31.4% of patients) and amphetamines (23.3%) were the most frequently involved and hallucinogens (1.9%) and ketamine (1.7%) the least. Overall, female patients were younger than males, both in the whole cohort (median age 29 vs. 32 years; p < 0.001) and in all drug groups except benzodiazepines (median age 36 vs. 36 years; p = 0.83). The relative proportion of each drug group was different at every age strata and some patterns could be clearly described: cannabis, NPS and hallucinogens were the most common in patients <20 years; amphetamines, ketamine and cocaine in the 20- to 39-year group; GHB/GBL in the 30- to 39-year group; and opioids and benzodiazepines in patients ≥40 years. Ethanol and other drug co-ingestion was more frequent at middle-ages, and multidrug co-ingestion was more common in females than males. CONCLUSION: Differences in the drugs involved in acute drug toxicity presentations according to age and sex may be relevant for developing drug-prevention and education programs for some particular subgroups of the population based on the increased risk of adverse events in specific sex and/or age strata.
Asunto(s)
Servicio de Urgencia en Hospital/tendencias , Drogas Ilícitas/envenenamiento , Intoxicación/epidemiología , Uso Recreativo de Drogas/tendencias , Trastornos Relacionados con Sustancias/epidemiología , Enfermedad Aguda , Adolescente , Adulto , Factores de Edad , Anciano , Bases de Datos Factuales , Europa (Continente)/epidemiología , Femenino , Humanos , Drogas Ilícitas/clasificación , Masculino , Persona de Mediana Edad , Intoxicación/diagnóstico , Sistema de Registros , Medición de Riesgo , Factores de Riesgo , Factores Sexuales , Trastornos Relacionados con Sustancias/diagnóstico , Factores de Tiempo , Adulto JovenRESUMEN
BACKGROUND: This study was conducted to retrospectively assess the relationships between: rhabdomyolysis (quantified by creatine kinase (CK) activity) and kidney injury (quantified by serum creatinine concentration), sex, age, body temperature on admission, presence of seizures, and agitation or aggression in patients presenting to the Emergency Department with acute recreational drug toxicity. We also investigated the association with the substances ingested. METHODS: All presentations to the 16 sentinel Euro-DEN centres in 10 European countries with acute recreational drug toxicity during the first year of the Euro-DEN study (October 2013 to September 2014) were considered. Cases that had abnormal CK activity recorded as part of routine clinical care were divided into 3 cohorts depending on peak CK activity. Cases with normal CK activity were included as a control group (4th cohort). RESULTS: Only 1,015 (18.4%) of the 5,529 Euro-DEN presentations had CK activity concentration recorded. Of this group 353 (34.8%) had also creatinine concentration measured. There were 375 (36.9%) with minor rhabdomyolysis, 69 (6.8%) with moderate rhabdomyolysis, and 24 (2.4%) with severe rhabdomyolysis; 547 (53.9%) were included in the control group. There was a positive correlation between CK activity and creatinine concentration (correlation coefficient r = 0.71, p<0.0001). There was no correlation between CK activity and body temperature at the time of presentation to the ED (correlation coefficient r = 0.07, p = 0.03). There was a positive correlation between CK activity and length of stay in the hospital (r = 0.31, p<0.001). There was no association between CK activity and the presence of seizures (p = 0.33) or agitation/aggression (p = 0.45), patients age (p = 0.4) or sex (p = 0.25). The 5 most common agents amongst patients presenting with rhabdomyolysis were: cocaine (n = 107; 22.9% presentations), amphetamine (76; 16.2%), cannabis (74; 15.8%), GHB/GBL (72; 15.4%) and heroin (67; 14.3%). The distribution of rhabdomyolysis in 5 most common drugs was (drug; patients with rhabdomyolysis, patients without rhabdomyolysis): cocaine (107, 122), cannabis (74, 117), GHB/GBL (72, 81), amphetamine (76, 66), heroin (67, 70). CONCLUSIONS: Abnormal values of CK activity occurred in almost half (46.1%) of presentations to the Emergency Department with acute recreational drug toxicity in whom CK activity was measured; however, severe rhabdomyolysis is seen in only a small minority (2.4%). Those with rhabdomyolysis are at significantly higher risk of kidney injury and have a longer length of hospital stay.
Asunto(s)
Creatina Quinasa/análisis , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/clasificación , Rabdomiólisis/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Temperatura Corporal , Estudios de Casos y Controles , Niño , Creatinina/sangre , Servicio de Urgencia en Hospital , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Rabdomiólisis/inducido químicamente , Rabdomiólisis/metabolismo , Adulto JovenRESUMEN
The General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), regularly organises market surveillance studies on specific categories of suspected illegal or illegally traded products. These studies are generally based on a combination of retrospective and prospective data collection over a defined period of time. This paper reports the results of the most recent study in this context with the focus on health products containing non-Anatomical Therapeutic Chemical-International Nonproprietary Name (ATC-INN) molecules. In total 1104 cases were reported by 16 countries for the period between January 2017 and the end of September 2019. The vast majority of these samples (83%) were collected from the illegal market, while only 3% originated from a legal source. For the rest of the samples, categorisation was not possible. Moreover, 69% of all the reported samples were presented as medicines, including sexual performance enhancers, sports performance enhancers, physical performance enhancers and cognitive enhancers or nootropic molecules that act on the central nervous system (CNS). Although the popularity of anabolics, PDE-5 inhibitors and CNS drugs in illegal products has already been reported, the study showed some new trends and challenges. Indeed, 11% of the samples contained molecules of biological origin, that is, research peptides, representing the second most reported category in this study. Furthermore, the study also clearly shows the increasing popularity of Selective Androgen Receptor Modulators and nootropics, two categories that need attention and should be further monitored.
Asunto(s)
Comercio/legislación & jurisprudencia , Control de Medicamentos y Narcóticos , Drogas Ilícitas/provisión & distribución , Sustancias para Mejorar el Rendimiento/provisión & distribución , Comercio/tendencias , Europa (Continente) , Humanos , Drogas Ilícitas/clasificación , Drogas Ilícitas/legislación & jurisprudencia , Sustancias para Mejorar el Rendimiento/clasificación , Estudios Prospectivos , Estudios Retrospectivos , Terminología como AsuntoRESUMEN
In Japan over the past few years, approximately 13,000 individuals were arrested for drug offenses each year. It is useful to know the trends in drug offenses, in order to devise the most effective countermeasures and addiction treatment programs. Herein, we have revealed the trends in drug offenses in the Tokyo Metropolitan Area. This report was researched the number of individuals arrested for drug offenses in Tokyo during the 3-year study period 2016-2018. The drugs are classified into the six categories: stimulants, narcotics, psychoactive drugs, opium, cannabis, and designated substances. We also calculated the percentages of individuals arrested for various drug offenses based on these six categories. Approximately 86% of the arrests for drug offenses in Tokyo during the 3-year period were for stimulants or cannabis. A higher percentage of individuals were arrested for stimulants, but the percentage of individuals arrested for cannabis increased each year. Given the percentage of individuals arrested for designated substances or narcotics, preventive measures for drug offenses involving stimulants and cannabis should be promptly implemented. Further campaigns to prevent drug offenses and public lectures are also needed. Public education must be provided to prevent drug offenses involving designated substances and narcotics.
Asunto(s)
Crimen/estadística & datos numéricos , Crimen/tendencias , Drogas Ilícitas , Cannabis , Estimulantes del Sistema Nervioso Central , Crimen/prevención & control , Drogas de Diseño , Humanos , Drogas Ilícitas/clasificación , Narcóticos , Opio , Psicotrópicos , Tokio/epidemiologíaRESUMEN
El análisis de aguas residuales con fines epidemiológicos es actualmente una herramienta fiable y complementaria a las metodologías basadas en indicadores tradicionales para el control de diferentes sustancias entre las que cabe destacar las drogas. Si bien varios países europeos la utilizan como herramienta de trabajo para la monitorización de drogas de abuso, en España su uso se limita principalmente a estudios realizados por diferentes grupos de investigación, tal y como se describe en el caso práctico puesto de ejemplo en el artículo. Sin embargo, el potencial de la metodología ha quedado evidenciado en los estudios científicos llevados a cabo tanto a nivel español como internacional y, aunque son necesarios más estudios para llegar a conocer todo su potencial, se prevé pueda ser incorporada como herramienta de trabajo complementaria a las que habitualmente se utilizan. En este sentido, la Red Española de Análisis de Aguas Residuales (ESAR-Net), creada en 2017 y formada por diferentes grupos de investigación españoles, pretende contribuir al conocimiento y aplicación de esta metodología en España a través de actividades científicas y de divulgación
Wastewater-Based Epidemiology is currently a reliable and complementary tool to methodologies based on traditional indicators for the control of various substances such as drugs. Although several European countries use it as a working tool for the monitoring of drugs of abuse, in Spain its use is mainly limited to studies carried out by different research groups, as described in the case study used as an example in the article. However, the potential of the methodology has been demonstrated in the scientific studies carried out both at the Spanish and international level and, although more studies are necessary to get to know its full potential, it is expected that it could be incorporated as a complementary work tool to those that are usually used. In this sense, the Red Española de Análisis de Aguas Residuales (ESAR-Net), created in 2017 and formed by different Spanish research groups, aims to contribute to the knowledge and application of this methodology in Spain through scientific and outreach activities
Asunto(s)
Humanos , Monitoreo del Ambiente , Aguas Residuales/química , Drogas Ilícitas/análisis , Detección de Abuso de Sustancias/métodos , Trastornos Relacionados con Sustancias/epidemiología , Aguas Residuales/análisis , Drogas Ilícitas/clasificación , EspañaRESUMEN
In recent years, the social media, the press and the internet have reported more about the topic of "legal highs" and new psychoactive substances (NPS). The use of these drugs is accompanied by a serious risk of undesired side effects, intoxication and even death. The often unknown chemical composition, unspecific clinical presentations and lack of quickly available routine diagnostic tests are aggravating factors in this situation. For anesthesiologists, knowledge of this dangerous substance class plays an important role in the field of preclinical treatment, perioperative management and intensive medical care.
Asunto(s)
Anestesiólogos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/clasificación , Trastornos Relacionados con Sustancias/epidemiología , Adolescente , Animales , Femenino , Humanos , Masculino , Trastornos Relacionados con Sustancias/diagnóstico , Adulto JovenRESUMEN
OBJECTIVES: Chemsex refers to the use of sex-enhancing drugs among men who have sex with men (MSM) in combination with specific sexual and social behaviours. Longitudinal data on this development and the associated health risks are scarce. METHODS: Data on all recreational drugs reported in the Swiss HIV Cohort Study (SHCS) from 2007 to 2017 were collected. Drug use was analysed longitudinally for all drug classes. In addition, potential associations between patient characteristics and the consumption of methamphetamine, γ-hydroxybutric acid/γ-butyrolactone (GHB/GBL), 3,4-methylenedioxymethamphetamine (MDMA/XTC), cocaine and amphetamine were analysed. RESULTS: We analysed 166 167 follow-up entries for 12 527 SHCS participants, including 7101 free text field entries containing information about recreational drugs other than cannabis, cocaine and heroin. Overall, we observed a stable percentage (9.0%) of recreational drug use (excluding cannabis, amyl nitrite and prescription drugs). For MSM, however, there was an increase in overall drug use from 8.8% in 2007 to 13.8% in 2017, with particularly large increases for methamphetamine (from 0.2 to 2.4%; P < 0.001) and GHB/GBL (from 1.0 to 3.4%; P < 0.001). The use of each of the potentially sex-enhancing drugs methamphetamine, GHB/GBL, cocaine, XTC/MDMA and amphetamine was significantly associated with condomless sex with nonsteady partners, and higher prevalences of depression, syphilis and hepatitis C. CONCLUSIONS: The significant increase in the use of chemsex drugs among MSM in the SHCS and the strong association with coinfections and depression highlights the need for harm reduction programmes tailored to MSM. According to our results, improving knowledge about recreational drugs is important for all health care professionals working with people living with HIV.
Asunto(s)
Infecciones por VIH/epidemiología , Drogas Ilícitas/clasificación , Uso Recreativo de Drogas/estadística & datos numéricos , Conducta Sexual/psicología , Adulto , Estudios Transversales , Femenino , Infecciones por VIH/psicología , Homosexualidad Masculina/psicología , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Uso Recreativo de Drogas/psicología , Suiza/epidemiologíaRESUMEN
Background The consumption of illicit drugs in Chile has increased over the years generating abuse and dependence problems and becoming a public health problem. Aim To build and disseminate a figure in which health personnel can quickly visualize illicit drugs and their common names, and thus be able to associate them with the effects and risks that are expected in the patient. Material and Methods A bibliographic review and compilation of information obtained from dealers and drug abusers. Results A figure and a table were developed. The former illustrates the classification and common names of drugs, while the second indicates the mechanisms of action and effects expected in the body according to each drug of abuse. Conclusions Illicit drugs have several popular names and various mechanisms of action. When confronting drug consumption this information is crucial to provide an adequate treatment and withdrawal management. However, it is important to keep in mind that this work only represents a management guide and that treatment should always focus on the condition and clinical manifestations of the patient.
Asunto(s)
Humanos , Drogas Ilícitas/clasificación , Trastornos Relacionados con Sustancias , Terminología como Asunto , Chile , Cultura PopularRESUMEN
Introducción. Pese a que el consumo de drogas se remonta a tiempo inmemoriales, con la ilegalización de éstas están surgiendo sustancias con efectos similares aprovechando vacíos legales, donde la enfermera tiene un papel muy importante en el proceso de prevención, tratamiento y desintoxicación de las mismas. Objetivos. Analizar los grupos de drogas emergentes más relevantes según su popularidad y perjuicios para la salud. Metodología. Se realizó una búsque-da bibliográfica en CINAHL, Medline, Dialnet, Scielo, la biblioteca virtual de la Universidad de Huelva, Google Académico y en la web del Observatorio Español de Drogas y toxicomanías basada en las palabras claves: dro-gas, emergentes, emergencia, enfermera, adicciones, drogas de diseño, prehistoria, tratamiento, MDMA, bath salts, Flakka, Mefedrona, marihuana sintética, cannabinoides sintéticos, Kratom, Metoxetamina, Poppers, Salvia Divinorum, así como sus equiva-lentes en inglés. Resultados. Los cannabinoides sin-téticos son sustancias mucho más potentes que la marihuana. Las catinonas sintéticas o sales de baño suelen provocar efectos adversos varios y muy peligrosos, llegando a existir gran variedad de sales de baño. El kratom y la Salvia Divinorum son sustancias de origen vegetal provenientes de países tropicales en los que tradicionalmente se les ha dado uso terapéutico. En occidente se está consumiendo con fines de ocio. La metoxetamina es una droga que ha surgido para reemplazar a la ketamina, ya que no posee tantos efectos secundarios. Los poppers son sus-tancias volátiles que se suelen inhalar y suelen usarse a la hora de mantener relaciones sexuales. Conclusiones. Se necesita más investigación acerca de estas sustancias en continua evolución. El papel de la enfermera en el ámbito de las adicciones resulta fundamental para alcanzar resultados deseables
Introduction. Although Drug consumption dates back to time immemorial, nowadays, with the outlawing of these drugs, emerging substances with similar effects are taking advantage of legal gaps, where the nurse has an important role in the process of prevention, treatment and drug detoxification. Objectives. To analyze the most relevant emerging drug groups according to their popularity and health damages. Methodology. A bibliographic search was carried out in CINAHL, Medline, Dialnet, Scielo, the virtual library of the University of Huelva, Google Scholar and on the website of the Spanish Observatory of Drugs and Addiction, based on the keywords: drugs, emergencies, emergency, nurse, addictions, designer drugs, prehistory, treatment, MDMA, bath salts, Flakka, Mephedro-ne, synthetic marijuana, synthetic cannabinoids, Kratom, Methoxyethamine, Poppers, Salvia Divinorum. Results. Synthetic cannabinoids are much more potent substances than marijuana. Synthetic cathinones or bath salts usually cause several and very dangerous adverse effects, reaching to a wide variety of bath salts. Kratom and Salvia Divinorum are substances of vegetable origin from tropical countries, where they have been traditionally used for therapy. In the West it is being consumed for leisure purposes. Methoxetamine is a drug that has arisen to replace ketamine because it has not many secondary effects. Poppers are volatile substances that are usually inhaled and often used to have sex. Conclusions. More research is needed on these continually evolving substances. The role of the nurse in the field of addiction is essential to achieve desirable results
Asunto(s)
Humanos , Trastornos Relacionados con Sustancias/rehabilitación , Trastornos Relacionados con Sustancias/enfermería , Drogas Ilícitas/clasificación , Drogas de Diseño/clasificaciónRESUMEN
Los servicios de análisis de sustancias son dispositivos de reducción de riesgos y daños que proporcionan a las personas usuarias de los mismos información objetiva sobre la composición de las drogas que van a tomar, así como un asesoramiento personalizado que les permita una gestión del consumo de cara a evitar o minimizar riesgos. Gracias a la información obtenida a través de estos servicios, es posible monitorizar los mercados de drogas a diferentes niveles y promover respuestas rápidas ante fenómenos emergentes. En el presente trabajo se exponen las características principales de estos servicios, un breve recorrido por su implementación en España, sus ventajas como estrategias para la reducción de riesgos y daños así como sus limitaciones y las críticas recibidas por sus detractores
Drug checking services are risk and harm reduction initiatives that provide users with objective information on the composition of the drugs they are going to take. These services also provide personalized advice meaning they are able to manage their consumption in order to avoid or minimize risks. Thanks to the information obtained through these services, it is possible to monitor drug markets at different levels and foster rapid responses to emerging phenomena. The main characteristics of these services, a brief overview of their implementation in Spain, their advantages as harm reduction strategies as well as their limitations and the criticisms received by their detractors are presented in this paper
Asunto(s)
Humanos , Reducción del Daño , Conducta de Reducción del Riesgo , Drogas Ilícitas/análisis , Drogas Ilícitas/clasificación , Trastornos Relacionados con Sustancias/prevención & controlRESUMEN
BACKGROUND: Understanding emergency department and healthcare utilisation related to acute recreational drug toxicity (ARDT) generally relies on nationally collated data based on ICD-10 coding. Previous UK studies have shown this poorly captures the true ARDT burden. The aim of this study was to investigate whether this is also the case elsewhere in Europe. METHODS: The Euro-DEN Plus database was interrogated for all presentations 1st July to 31st December 2015 to the EDs in (i) St Thomas' Hospital, London, UK; (ii) Universitätsspital Basel, Basel, Switzerland; and (iii) Zealand University Hospital, Roskilde, Denmark. Comparison of the drug(s) involved in the presentation with the ICD-10 codes applied to those presentations was undertaken to determine the proportion of cases where the primary/subsequent ICD-10 code(s) were ARDT related. RESULTS: There were 619 presentations over the 6-month period. Two hundred thirteen (34.4%) of those presentations were coded; 89.7% had a primary/subsequent ARDT-related ICD-10 code. One hundred percent of presentations to Roskilde had a primary ARDT ICD-10 code compared to 9.6% and 18.9% in Basel and London respectively. Overall, only 8.5% of the coded presentations had codes that captured all of the drugs that were involved in that presentation. CONCLUSIONS: While the majority of primary and secondary codes applied related to ARDT, often they did not identify the actual drug(s) involved. This was due to both inconsistencies in the ICD-10 codes applied and lack of ICD-10 codes for the drugs/NPS. Further work and education is needed to improve consistency of use of current ICD-10 and future potential ICD-11 coding systems.
Asunto(s)
Servicio de Urgencia en Hospital , Drogas Ilícitas/clasificación , Analgésicos Opioides/clasificación , Analgésicos Opioides/envenenamiento , Cannabis/clasificación , Cannabis/envenenamiento , Cocaína/clasificación , Cocaína/envenenamiento , Bases de Datos Factuales , Dinamarca , Sobredosis de Droga/diagnóstico , Servicios Médicos de Urgencia , Humanos , Drogas Ilícitas/envenenamiento , Drogas Ilícitas/toxicidad , Clasificación Internacional de Enfermedades , Metanfetamina/análogos & derivados , Metanfetamina/clasificación , Metanfetamina/envenenamiento , Suiza , Reino UnidoRESUMEN
Background The consumption of illicit drugs in Chile has increased over the years generating abuse and dependence problems and becoming a public health problem. Aim To build and disseminate a figure in which health personnel can quickly visualize illicit drugs and their common names, and thus be able to associate them with the effects and risks that are expected in the patient. Material and Methods A bibliographic review and compilation of information obtained from dealers and drug abusers. Results A figure and a table were developed. The former illustrates the classification and common names of drugs, while the second indicates the mechanisms of action and effects expected in the body according to each drug of abuse. Conclusions Illicit drugs have several popular names and various mechanisms of action. When confronting drug consumption this information is crucial to provide an adequate treatment and withdrawal management. However, it is important to keep in mind that this work only represents a management guide and that treatment should always focus on the condition and clinical manifestations of the patient.
Asunto(s)
Drogas Ilícitas/clasificación , Trastornos Relacionados con Sustancias , Terminología como Asunto , Chile , Humanos , Cultura PopularRESUMEN
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule seven fentanyl-related substances in schedule I. These seven substances are: N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl), N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl), N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl), N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl), and N-(2- fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil). This action is based on a finding by the Administrator that the placement of these seven synthetic opioids in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, valeryl fentanyl, para-fluorobutyryl fentanyl, para-methoxybutyryl fentanyl, para-chloroisobutyryl fentanyl, isobutyryl fentanyl, cyclopentyl fentanyl, and ocfentanil.
Asunto(s)
Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Fentanilo/clasificación , Fentanilo/efectos adversos , Fentanilo/análisis , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/clasificación , Salud Pública , Estados UnidosRESUMEN
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA) and their isomers, esters, ethers, salts and salts of isomers, esters, and ethers in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle fentanyl-related substances.
Asunto(s)
Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Fentanilo/clasificación , Fentanilo/efectos adversos , Fentanilo/análogos & derivados , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/clasificación , Salud Pública , Estados UnidosRESUMEN
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioids, N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl or 2-fluorofentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (tetrahydrofuranyl fentanyl), and 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl fentanyl), into Schedule I. This action is based on a finding by the Administrator that the placement of ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl.
Asunto(s)
Analgésicos Opioides/clasificación , Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Fentanilo/análisis , Fentanilo/clasificación , Analgésicos Opioides/efectos adversos , Fentanilo/efectos adversos , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/clasificación , Estados UnidosRESUMEN
BACKGROUND: Recent decades have seen substantial changes in the UK cannabis landscape, including increased domestic production, the ascendancy of stronger strains (namely 'skunk') and the drug's reclassification under the 1971 Misuse of Drugs Act. Resultantly, cannabis retains significance in the consciousness, priorities and policy agendas of communities, drug services and criminal justice agencies. METHODS: This paper presents an empirical study, which examined both perceptions and impacts of cannabis cultivation and its control within a North-West English borough. It draws on qualitative research with samples of professionals, practitioners, resident groups, cannabis users, cannabis users' families and cannabis cultivators themselves. FINDINGS: The findings suggest that cannabis cultivation was not a uniformly familiar concept to respondents, who had limited knowledge and experience of its production. Across all participant groups, the transmission of accurate information was lacking, with individuals instead drawing on the reductionist drug discourse (Taylor, 2016) to fill knowledge deficits. Consequently, some participants conflated cannabis cultivation with wider prohibitionist constructions of drug markets, resulting in the diffusion of misinformation and an amplification of anxieties. In contrast, other participants construed cultivation as making economic sense during austerity, justifying such tolerance through inverse adherence to the same narrow socio-cultural construction of drugs i.e. that cultivation carried comparatively less harms than real drug markets. Enforcement mechanisms also drew on generic prohibitionist conceptions, assuming cultivators to be unconstrained, autonomous actors in need of punishment; a belief which lacked nuanced understanding of the local terrain where vulnerable individuals cultivating under duress played a key role in the supply chain. CONCLUSION: The paper concludes with a call for the provision of accessible information/education; the need to challenge and reconceptualise the assumed autonomy and resultant punity directed at all cannabis cultivators; and a subsequent need to reassess established forms of legal (and increasingly social) enforcement.
Asunto(s)
Cannabis/crecimiento & desarrollo , Drogas Ilícitas/legislación & jurisprudencia , Legislación de Medicamentos , Fumar Marihuana/legislación & jurisprudencia , Cannabis/clasificación , Control de Medicamentos y Narcóticos , Humanos , Drogas Ilícitas/clasificación , Reino UnidoRESUMEN
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into Schedule I. This action is based on a finding by the Administrator that the placement of acryl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, acryl fentanyl.
Asunto(s)
Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Fentanilo/clasificación , Analgésicos Opioides/clasificación , Fentanilo/análisis , Humanos , Drogas Ilícitas/clasificación , Drogas Ilícitas/legislación & jurisprudencia , Salud Pública , Estados UnidosRESUMEN
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of 4-fluoroisobutyryl fentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 4-fluoroisobutyryl fentanyl.
Asunto(s)
Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Fentanilo/clasificación , Fentanilo/efectos adversos , Fentanilo/análogos & derivados , Humanos , Drogas Ilícitas/clasificación , Legislación de Medicamentos , Salud Pública , Estados UnidosRESUMEN
With the issuance of this final rule, the Drug Enforcement Administration places 10 synthetic cathinones: 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible, into schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This rule continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle 4-MEC, 4-MePPP, [alpha]-PVP, butylone, pentedrone, pentylone, 4-FMC, 3- FMC, naphyrone, or [alpha]-PBP.